Coupling Drug Dissolution with BCS
Pharmaceutical Research · 2024
DOI: 10.1007/s11095-024-03661-x ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceutical Research, 2024. Verfasst von Antony Simitopoulos und 2 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmacy, National and Kapodistrian University of Athens, Athens, Greece. Hauptthemen laut MEDLINE: Biopharmaceutics. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Athens.
Abstract (Originalsprache)
Purpose
The purpose of this study is to develop a Temporal Biopharmaceutic Classification System (T-BCS), linking Finite Dissolution Time (F.D.T.) and Mean Dissolution Time (M.D.T.) for Class I/III drugs and Mean Dissolution Time for saturation (M.D.T.s.) for Class II/IV drugs.
Methods
These parameters are estimated graphically or by fitting dissolution models to experimental data and coupled with the dose-to-solubility ratio ( q ) for each drug normalized in terms of the actual volume of dissolution medium (900 mL).
Results
Class I/III drugs consistently exhibited q values less than 1, aligning with expectations based on their solubility, while some Class II/IV drugs presented a deviation from anticipated q values, with observations of q < 1. This irregularity was rendered to the dissolution volume of 250 mL used for biopharmaceutical classification purposes instead of 900 mL applied as well as the dual classification of some sparingly soluble drugs. Biowaivers were also analyzed in terms of M.D.T., F.D.T. estimates and the regulatory dissolution time limits for rapidly and very-rapidly dissolved drugs.
Conclusions
The T-BCS is useful for establishing correlations and assessing the magnitude of M.D.T., F.D.T., or M.D.T.s. for inter- and intra-class comparisons of different drugs and provide relationships between these parameters across all the models that were utilized. Graphical Abstract
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Pharmacy, National and Kapodistrian University of Athens, Athens, Greece.
- Department of Chemistry, National and Kapodistrian University of Athens, Athens, Greece.
- PharmaInformatics Unit, ATHENA Research Center, Athens, Greece.
- Faculty of Pharmacy, National and Kapodistrian University of Athens, Athens, Greece. macheras@pharm.uoa.gr.
- PharmaInformatics Unit, ATHENA Research Center, Athens, Greece. macheras@pharm.uoa.gr.
Förderung
- University of Athens
Zitieren
APA
Simitopoulos, A., Tsekouras, A., & Macheras, P. (2024). Coupling Drug Dissolution with BCS. Pharmaceutical Research. https://doi.org/10.1007/s11095-024-03661-x
Vancouver
Simitopoulos A, Tsekouras A, Macheras P. Coupling Drug Dissolution with BCS. Pharmaceutical Research. 2024. doi:10.1007/s11095-024-03661-x
BibTeX
@article{Simitopoulos2024,
author = {Simitopoulos, Antony and Tsekouras, Athanasios and Macheras, Panos},
title = {Coupling Drug Dissolution with BCS},
journal = {Pharmaceutical Research},
year = {2024},
doi = {10.1007/s11095-024-03661-x}
}
EUVIMED